Vector-borne diseases (VBDs) represent a significant public health challenge in India, responsible for substantial morbidity and mortality. This article aims to provide a comprehensive review of VBDs in India, with a focus on understanding their prevalence and developing effective strategies to combat them.
India's diverse topography and climatic conditions contribute to the prevalence of various VBDs. Malaria, dengue, and chikungunya are the most commonly reported, while emerging diseases like Zika and Kala-azar also pose significant threats. The World Health Organization estimates that India accounts for 89% of South-East Asia's VBDs, highlighting the urgency of addressing this issue.
Several factors contribute to the difficulty in managing VBDs in India. These include a lack of public awareness, inadequate health infrastructure, rapid urbanization, and climate change. Additionally, the high genetic variability of vectors and pathogens complicates the development of effective vaccines and therapeutics.
Efforts to control VBDs in India should focus on integrated vector management, including environmental management and biological control methods. Enhanced surveillance systems, community participation, and intersectoral coordination are crucial. Furthermore, investment in research and development for effective vaccines and therapeutics is imperative.
Healthcare professionals play a pivotal role in combating VBDs. They are instrumental in early detection and prompt treatment, reducing disease transmission. Additionally, they can contribute to public health education, promoting preventive measures and improving community engagement in control programs.
Addressing the burden of VBDs in India requires a comprehensive, multi-faceted approach. Understanding the epidemiology, overcoming challenges, and implementing effective control strategies are key. Healthcare professionals, with their unique roles and responsibilities, are critical in this endeavor, underscoring the need for continuous professional development in this area.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation